Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2018

Nov 30, 2018

29777_dirs_2018-11-30_b20c9a33-a0f6-4827-a62e-8c23e38468f3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2018-11-28

Reporting Person: WHITE MILES D (Director, Chairman and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-11-28 Common shares without par value S 1600 $72.575 Disposed 3138104 Direct
2018-11-28 Common shares without par value S 400 $72.58 Disposed 3137704 Direct
2018-11-28 Common shares without par value S 2900 $72.585 Disposed 3134804 Direct
2018-11-28 Common shares without par value S 500 $72.59 Disposed 3134304 Direct
2018-11-28 Common shares without par value S 119 $72.595 Disposed 3134185 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 32887 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of November 28, 2018.